HIGHLIGHTS
- who: Zhiqi Zhang from the Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China have published the Article: Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study, in the Journal: (JOURNAL)
- what: The authors aimed to analyze the safety and efficacy of anticoagulants for patients with cirrhotic PVT through a cohort study in a tertiary hospital. A ChildPugh grade C patient included in the study had good safety and effectiveness after taking rivaroxaban for 8 months, but larger sample studies with larger sample sizes are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.